E. Alyea

发表

Efficacious immune therapy in chronic myelogenous leukemia (CML) recognizes antigens that are expressed on CML progenitor cells.

Vladimir Brusic, Donna Neuberg, Fenglong Liu, 2010, Cancer research.

Serologic markers of effective tumor immunity against chronic lymphocytic leukemia include nonmutated B-cell antigens.

D. Neuberg, J. Kutok, Catherine J. Wu, 2010, Cancer research.

Mucositis after allogeneic hematopoietic stem cell transplantation: a cohort study of methotrexate- and non-methotrexate-containing graft-versus-host disease prophylaxis regimens.

R. Soiffer, Stephanie J. Lee, S. Sonis, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Prior gemtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allogeneic stem cell transplantation.

P. Richardson, D. Zahrieh, D. DeAngelo, 2003, Blood.

Survival following allogeneic transplant in patients with myelofibrosis.

N. Kröger, M. Arcasoy, S. Verstovsek, 2020, Blood advances.

Distinct evolutionary paths in chronic lymphocytic leukemia during resistance to the graft-versus-leukemia effect

A. Gnirke, D. Neuberg, D. Keskin, 2020, Science Translational Medicine.

Distinct evolutionary paths in chronic lymphocytic leukemia during resistance to graft-versus-leukemia

A. Gnirke, D. Neuberg, P. Kharchenko, 2020, bioRxiv.

Efficacy and immunologic effects of extracorporeal photopheresis plus interleukin-2 in chronic graft-versus-host disease.

J. Ritz, S. Nikiforow, J. Whangbo, 2019, Blood advances.

First International Workshop on the Biology , Prevention and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation : Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation

E. Estey, D. Porter, K. Peggs, 2010 .

NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.

E. Estey, D. Maloney, D. Porter, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Important drug interactions in hematopoietic stem cell transplantation: what every physician should know.

R. Soiffer, C. Duncan, E. Alyea, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Altered regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stem cell transplantation.

J. Ritz, R. Soiffer, Gregory Bascug, 2010, The Journal of clinical investigation.

CHAPTER 17: LEUKEMIA

J. Ritz, E. Ball, E. Alyea, 2001 .

Combined CD4+ donor lymphocyte infusion and low-dose recombinant IL-2 expand FOXP3+ regulatory T cells following allogeneic hematopoietic stem cell transplantation.

J. Ritz, R. Soiffer, Haesook T. Kim, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

An aggressive approach to prostatic cancer.

J. Glenn, E. Alyea, J. Dees, 1977, The Journal of urology.

Diagnosis and treatment of carcinoma of the prostate.

E. Alyea, E. Galleher, 1956, Postgraduate medicine.

Early or Late Orchiectomy for Carcinoma of the Prostate1

E. Alyea, 1945 .

Castration for Carcinoma of the Prostate: A Report of the Immediate Results1

A. F. Henderson, E. Alyea, 1942 .

CARCINOMA OF THE PROSTATE: IMMEDIATE RESPONSE TO BILATERAL ORCHIECTOMY; CLINICAL AND X-RAY EVIDENCE

A. F. Henderson, E. Alyea, 1942 .

Imaging of complications of hematopoietic stem cell transplantation.

P. Ros, R. Gill, J. Jagannathan, 2008, Radiologic clinics of North America.

Mapping the evolution of T cell states during response and resistance to adoptive cellular therapy

D. Pe’er, Shuqiang Li, K. Livak, 2020, bioRxiv.

Novel myeloma-associated antigens revealed in the context of syngeneic hematopoietic stem cell transplantation.

D. Neuberg, K. Anderson, Catherine J. Wu, 2008, Blood.

Iron overload in patients with acute leukemia or MDS undergoing myeloablative stem cell transplantation.

M. Fleming, H. Steen, R. Kwong, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

National Cancer Institute's First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: summary and recommendations from the organizing committee.

N. Kröger, D. Porter, C. June, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

GM-CSF Secreting Leukemia Cell Vaccination after Allogeneic Reduced Intensity Hematopoietic Stem Cell Transplantation for Advanced Myeloid Malignancies

G. Dranoff, R. Soiffer, Matthew W. Vanneman, 2008 .

GM-CSF Secreting Leukemia Cell Vaccinations after Allogeneic Reduced-Intensity Peripheral Blood Stem Cell Transplantation (SCT) for Advanced Myelodysplastic Syndrome (MDS) or Refractory Acute Myeloid Leukemia (AML).

G. Dranoff, R. Soiffer, C. Cutler, 2006 .

Fit Older Adults with Advanced Myelodysplastic Syndromes: Who is Most Likely to Benefit from Transplant?

G. Abel, D. DeAngelo, R. Soiffer, 2020, Leukemia.

A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Cell Transplant in Myelodysplastic Syndromes Patients.

R. Vij, W. Wood, M. Aljurf, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Outcomes after Umbilical Cord Blood Transplantation for Myelodysplastic Syndromes.

M. Aljurf, R. Gale, K. Ballen, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Scoring System Prognostic of Outcome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome.

Alan M. Miller, R. Vij, W. Wood, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Angiogenic Cytokines Are Antibody Targets During Graft-versus-Leukemia Reactions

P. Altevogt, G. Dranoff, J. Ritz, 2014, Clinical Cancer Research.

90Y-Ibritumomab tiuxetan followed by reduced-intensity conditioning and allogeneic stem-cell transplantation in patients with advanced follicular lymphoma

A. LaCasce, A. Freedman, K. Stevenson, 2010, Bone Marrow Transplantation.

Rituximab for steroid-refractory chronic graft-versus-host disease.

J. Ritz, D. Miklos, D. Bienfang, 2006, Blood.

Autologous CLL cell vaccination early after transplant induces leukemia-specific T cells.

D. Neuberg, Catherine J. Wu, G. Dranoff, 2013, The Journal of clinical investigation.

Biologic activity of irradiated, autologous, GM-CSF-secreting leukemia cell vaccines early after allogeneic stem cell transplantation

J. Kutok, M. Mihm, G. Dranoff, 2009, Proceedings of the National Academy of Sciences.

A multicenter, phase I study of nivolumab for relapsed hematologic malignancies after allogeneic transplantation.

Catherine J. Wu, J. Ritz, S. Nikiforow, 2020, Blood.

CML66, a broadly immunogenic tumor antigen, elicits a humoral immune response associated with remission of chronic myelogenous leukemia

P. Kantoff, Catherine J. Wu, G. Dranoff, 2001, Proceedings of the National Academy of Sciences of the United States of America.

Timing of allogeneic hematopoietic cell transplantation (alloHCT) for chronic myeloid leukemia (CML) patients

H. Kantarjian, G. Garcia-Manero, J. Cortes, 2020, Leukemia & lymphoma.

Myeloablative vs reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chronic myeloid leukemia.

R. Gale, H. Khoury, U. Popat, 2018, Blood advances.

Quantitative Monitoring of BCR / ABL Transcript During STI-571 Therapy

D. Neuberg, Catherine J. Wu, J. Ritz, 2002, Leukemia & lymphoma.

Harnessing Allogeneic Immunity for Anti-myeloma Response

E. Alyea, R. Bellucci, 2013 .

An asterisk indicates reviewers who have evaluated three or more manuscripts in 2012.

David Ball, Ash A. Alizadeh, David A. August, 2013 .

Haematopoietic cell transplantation with and without sorafenib maintenance for patients with FLT3‐ITD acute myeloid leukaemia in first complete remission

S. Nikiforow, K. Ballen, D. DeAngelo, 2016, British journal of haematology.

Safety and efficacy of denileukin diftitox in patients with steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

J. Ritz, D. Zahrieh, D. Fisher, 2004, Blood.

Impact of Conditioning Intensity and Genomics on Relapse After Allogeneic Transplantation for Patients With Myelodysplastic Syndrome

H. Deeg, D. Porter, G. Gui, 2020, medRxiv.

Donor-engrafted CHIP is common among stem cell transplant recipients with unexplained cytopenias.

J. Ritz, S. Nikiforow, R. Soiffer, 2017, Blood.

transplantation assessment of hematopoietic chimerism after allogeneic stem cell based method for - A novel rapid single nucleotide polymorphism (SNP)

D. Neuberg, J. Ritz, D. Miklos, 2013 .

Combined CD4 T-Cell and Antibody Response to Human Minor Histocompatibility Antigen DBY After Allogeneic Stem-Cell Transplantation

J. Ritz, D. Miklos, R. Soiffer, 2011, Transplantation.

Oral health status and risk of bacteremia following allogeneic hematopoietic cell transplantation.

A. Sultan, R. Soiffer, S. Sonis, 2017, Oral surgery, oral medicine, oral pathology and oral radiology.

Stromal-Derived Factor-1? The BCR/ABL Oncogene Alters the Chemotactic Response to

G. Daley, J. Griffin, M. Sattler, 2012 .

The BCR/ABL oncogene alters the chemotactic response to stromal-derived factor-1alpha.

G. Daley, R. Salgia, U. V. von Andrian, 1999, Blood.

Expansion of tumor-specific CD8+ T cell clones in patients with relapsed myeloma after donor lymphocyte infusion.

J. Ritz, R. Schlossman, P. Ghia, 2003, Cancer research.

A Rare Case of Duodenal Immunoglobulin M Infiltration in a Patient With Chronic Lymphocytic Leukemia

R. Yantiss, S. Ely, T. Narang, 2009, The American Journal of Gastroenterology.

The impact of ASCT on patients with newly diagnosed multiple myeloma who receive RVD induction

N. Munshi, J. Laubach, P. Richardson, 2013 .

Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease.

J. Ritz, R. Soiffer, Stephanie J. Lee, 2005, Blood.

Efficacy and Safety of 1% Progesterone Gel to the Forehead for Ocular Chronic Graft-versus-Host Disease.

P. Armand, R. Soiffer, C. Cutler, 2021, Transplantation and cellular therapy.

M. Vaduganathan, M. Davids, D. Berg, 2017, European journal of heart failure.

Infusion of CD4+ donor lymphocytes induces the expansion of CD8+ donor T cells with cytolytic activity directed against recipient hematopoietic cells.

J. Ritz, R. Soiffer, E. Hochberg, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Infusion of CD 4 Donor Lymphocytes Induces the Expansion of CD 8 Donor T Cells with Cytolytic Activity Directed against Recipient Hematopoietic Cells 1

J. Ritz, R. Soiffer, E. Hochberg, 2002 .

Recovery of B-cell homeostasis after rituximab in chronic graft-versus-host disease.

J. Ritz, K. Stevenson, R. Soiffer, 2011, Blood.

CTLA4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic cell transplantation.

I. Lowy, R. Soiffer, E. Ball, 2009, Blood.

CTLA 4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic cell transplantation

I. Lowy, R. Soiffer, E. Ball, 2009 .

BK virus-specific T-cell immune reconstitution after allogeneic hematopoietic cell transplantation.

J. Ritz, S. Nikiforow, P. Armand, 2020, Blood advances.

Granulocyte-macrophage colony-stimulating factor (GM-CSF)-secreting cellular immunotherapy in combination with autologous stem cell transplantation (ASCT) as postremission therapy for acute myeloid leukemia (AML).

W. Stock, D. DeAngelo, R. Stone, 2009, Blood.

Myeloablative versus Reduced-Intensity Conditioning for Hematopoietic Cell Transplantation in Acute Myelogenous Leukemia and Myelodysplastic Syndromes-Long-Term Follow-Up of the BMT CTN 0901 Clinical Trial.

E. Leifer, N. Geller, D. Porter, 2021, Transplantation and cellular therapy.

Randomized trial of CD8+ T-cell depletion in the prevention of graft-versus-host disease associated with donor lymphocyte infusion.

Catherine J. Wu, J. Ritz, D. Zahrieh, 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

α1-Antitrypsin infusion for treatment of steroid-resistant acute graft-versus-host disease.

T. Braun, R. Soiffer, C. Dinarello, 2018, Blood.

Seroprotective titers against 2009 H1N1 influenza A virus after vaccination in allogeneic hematopoietic stem cell transplantation recipients.

P. Armand, R. Soiffer, S. Koo, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease.

J. Ritz, K. Stevenson, R. Soiffer, 2009, Blood.

graft-versus-host disease Altered B-cell homeostasis and excess BAFF in human chronic

J. Ritz, K. Stevenson, R. Soiffer, 2009 .

Phase 1 clinical trial evaluating abatacept in patients with steroid-refractory chronic graft-versus-host disease.

R. Soiffer, R. Joyce, Shuli Li, 2016, Blood.

Costs of allogeneic hematopoietic cell transplantation using reduced intensity conditioning regimens.

B. Sandmaier, B. Storer, Stephanie J. Lee, 2013, The oncologist.

Conditioning Regimens Costs of Allogeneic Hematopoietic Cell Transplantation Using Reduced Intensity

B. Sandmaier, B. Storer, N. Khera, 2014 .

Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation.

P. Armand, R. Soiffer, C. Cutler, 2007, Blood.

Donor lymphocyte infusions.

V. Ho, E. Alyea, 2004, Advances in pharmacology.

ATP6S1 elicits potent humoral responses associated with immune-mediated tumor destruction

D. Neuberg, M. Mihm, F. Hodi, 2002, Proceedings of the National Academy of Sciences of the United States of America.

Cord-blood hematopoietic stem cell transplant confers an increased risk for human herpesvirus-6-associated acute limbic encephalitis: a cohort analysis.

P. Armand, R. Soiffer, S. Koo, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Double umbilical cord blood transplantation with reduced intensity conditioning and sirolimus-based GVHD prophylaxis

J. Ritz, J. Brown, K. Stevenson, 2011, Bone Marrow Transplantation.

High-grade heart block associated with ibrutinib therapy

E. Jacobsen, J. Moslehi, Jennifer R. Brown, 2021, HeartRhythm case reports.

B. Yeap, K. Ballen, R. Soiffer, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes.

E. Leifer, N. Geller, H. Deeg, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of Cytogenetics and Prior Therapy on Outcome of AML and MDS after Allogeneic Transplantation.

J. Ritz, P. Armand, D. DeAngelo, 2006 .

Outcomes of Allogeneic Hematopoietic Cell Transplantation in Children (<18y) and Young adults (18–29y) with Chronic Myeloid Leukemia: A CIBMTR Cohort Analysis

W. Wood, R. Sparapani, R. Gale, 2016 .

The Role of Donor Lymphocyte Infusion (DLI) in Post Hematopoietic Cell Transplant (HCT) Relapse for Chronic Myeloid Leukemia (CML) in the Tyrosine Kinase Inhibitor (TKI) Era.

R. Vij, M. Aljurf, J. Szer, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Genetic factors rather than blast reduction determine outcomes of allogeneic HCT in BCR-ABL-negative MPN in blast phase.

H. Deeg, U. Popat, J. Capo-Chichi, 2020, Blood advances.

Comparison of outcomes of HCT in blast phase of BCR-ABL1- MPN with de novo AML and with AML following MDS.

Y. Liu, M. Aljurf, J. Szer, 2020, Blood advances.

Predictors of improved progression-free survival after nonmyeloablative allogeneic stem cell transplantation for advanced chronic lymphocytic leukemia.

J. Gribben, J. Ritz, D. Fisher, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Hematopoietic stem-cell transplantation for advanced systemic mastocytosis.

L. Pagano, M. Perales, I. Yakoub-Agha, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Efficacy and costs of granulocyte colony-stimulating factor in allogeneic T-cell depleted bone marrow transplantation.

J. Ritz, R. Soiffer, E. Weller, 1998, Blood.

Phase II trial of parathyroid hormone after double umbilical cord blood transplantation.

E. Shpall, J. Wingard, K. Ballen, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Phase II Trial of Parathyroid Hormone following Double Umbilical Cord Blood Transplantation

E. Shpall, J. Wingard, K. Ballen, 2012 .

Graft-Versus-Host Disease Prevention: Corticosteroids Revisited.

E. Alyea, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Antibodies targeting surface membrane antigens in patients with chronic graft-versus-host disease.

J. Ritz, S. Nikiforow, P. Armand, 2017, Blood.

A phase II study of bortezomib plus prednisone for initial therapy of chronic graft-versus-host disease.

J. Ritz, S. Nikiforow, P. Armand, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma.

A. LaCasce, D. Neuberg, B. Ebert, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comparison of Tacrolimus and Sirolimus ( Tac / Sir ) versus Tacrolimus , Sirolimus , and mini-methotrexate ( Tac / Sir / Mtx ) as Acute GVHD Prophylaxis after Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation

R. Soiffer, C. Cutler, Haesook T. Kim, 2009 .

Extended follow-up of methotrexate-free immunosuppression using sirolimus and tacrolimus in related and unrelated donor peripheral blood stem cell transplantation.

R. Soiffer, Shuli Li, C. Cutler, 2007, Blood.

Bortezomib, tacrolimus, and methotrexate for prophylaxis of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation from HLA-mismatched unrelated donors.

J. Ritz, K. Stevenson, P. Armand, 2009, Blood.

Phase II trial of natalizumab with corticosteroids as initial treatment of gastrointestinal acute graft-versus-host disease

S. Nikiforow, P. Armand, R. Soiffer, 2020, Bone Marrow Transplantation.

Prostaglandin-modulated umbilical cord blood hematopoietic stem cell transplantation.

L. Zon, W. Goessling, C. Desponts, 2013, Blood.

Donor-specific anti-HLA antibodies predict outcome in double umbilical cord blood transplantation.

J. Ritz, P. Armand, K. Ballen, 2011, Blood.

Effect of Antihuman T Lymphocyte Globulin on Immune Recovery after Myeloablative Allogeneic Stem Cell Transplantation with Matched Unrelated Donors: Analysis of Immune Reconstitution in a Double-Blind Randomized Controlled Trial.

J. Ritz, P. Westervelt, J. Dipersio, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Unbalanced recovery of regulatory and effector T cells after allogeneic stem cell transplantation contributes to chronic GVHD.

J. Ritz, S. Nikiforow, J. Whangbo, 2016, Blood.

Differential epitope mapping of antibodies to PDC-E2 in patients with hematologic malignancies after allogeneic hematopoietic stem cell transplantation and primary biliary cirrhosis.

N. Munshi, J. Ritz, Sigui Li, 2007, Blood.

Outcomes of HLA Matched Sibling Donor Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia: Myeloablative vs. Reduced-Intensity Conditioning Regimens

J. Cortes, M. Aljurf, I. Lewis, 2014 .

CD 6-Depleted Allogeneic Bone Marrow Transplantation for Acute Leukemia in First Complete Remission

D. Fairclough, J. Ritz, A. Freedman, 1997 .

BK virus-specific T-cell immune reconstitution after allogeneic hematopoietic cell transplantation.

J. Ritz, S. Nikiforow, P. Armand, 2016, Blood advances.

Circulating T follicular helper cells with increased function during chronic graft-versus-host disease.

J. Ritz, S. Nikiforow, P. Armand, 2016, Blood.

Low risk of chronic graft-versus-host disease and relapse associated with T cell-depleted peripheral blood stem cell transplantation for acute myelogenous leukemia in first remission: results of the blood and marrow transplant clinical trials network protocol 0303.

P. Hari, M. Pasquini, R. Soiffer, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Results of a Phase III Randomized, Multi-Center Study of Allogeneic Stem Cell Transplantation after High Versus Reduced Intensity Conditioning in Patients with Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML): Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0901

E. Leifer, N. Geller, H. Deeg, 2015 .

Effect of total body irradiation dose escalation on outcome following T-cell-depleted allogeneic bone marrow transplantation.

J. Gribben, D. Neuberg, J. Ritz, 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

T-cell--depleted allogeneic bone marrow transplantation followed by donor lymphocyte infusion in patients with multiple myeloma: induction of graft-versus-myeloma effect.

J. Gribben, J. Ritz, R. Soiffer, 2001, Blood.

Impaired T- and NK-cell reconstitution after haploidentical HCT with posttransplant cyclophosphamide.

Catherine J. Wu, J. Ritz, S. Nikiforow, 2021, Blood advances.

Ipilimumab for Patients with Relapse after Allogeneic Transplantation.

Catherine J. Wu, F. Hodi, Michael S. Rooney, 2016, The New England journal of medicine.

Sirolimus-based graft-versus-host disease prophylaxis protects against cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation: a cohort analysis.

I. Bassett, R. Soiffer, S. Browne, 2007, Blood.

Intradermal test for sensitivity to iodopyracet injection, or diodrast.

E. Alyea, C. Haines, 1947, Journal of the American Medical Association.

Sequential infusion of donor‐derived dendritic cells with donor lymphocyte infusion for relapsed hematologic cancers after allogeneic hematopoietic stem cell transplantation

J. Ritz, R. Soiffer, R. Joyce, 2014, American journal of hematology.

Prognostic Impact of Elevated Serum Ferritin in Patients Undergoing Myeloablative Stem Cell Transplantation.

P. Armand, R. Soiffer, C. Cutler, 2006 .

Phase I study of alemtuzumab for therapy of steroid-refractory chronic graft-versus-host disease.

J. Ritz, S. Nikiforow, P. Armand, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Prediction of veno-occlusive disease using biomarkers of endothelial injury.

P. Richardson, J. Ritz, P. Armand, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The Addition Of Sirolimus To The Gvhd Prophylaxis Regimen In Reduced Intensity Allogeneic Stem Cell Transplantation For Lymphoma: A Multicenter Randomized Trial

R. Soiffer, Yi-Bin Chen, S. McAfee, 2013 .

Sirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation.

R. Soiffer, Stephanie J. Lee, C. Magee, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Improved Treatment-Related Mortality and Overall Survival of Patients with Grade IV Acute GVHD in the Modern Years.

S. Nikiforow, P. Armand, K. Ballen, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

transplantation: a cohort analysis cytomegalovirus reactivation after allogeneic hematopoietic stem cell Sirolimus-based graft-versus-host disease prophylaxis protects against

R. Soiffer, S. Browne, F. Marty, 2011 .

Maximizing GVL in allogeneic transplantation: role of donor lymphocyte infusions.

S. Nikiforow, E. Alyea, 2014, Hematology. American Society of Hematology. Education Program.

An Open-Label Phase II Randomized Trial of Topical Dexamethasone and Tacrolimus Solutions for the Treatment of Oral Chronic Graft-versus-Host Disease.

A. Sultan, P. Armand, R. Soiffer, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Hypertension and the surgical kidney.

E. Alyea, A. Puppel, 1952, The Journal of urology.

Outcomes of Allogeneic Hematopoietic Cell Transplantation in Children and Young Adults with Chronic Myeloid Leukemia: A CIBMTR Cohort Analysis.

W. Wood, R. Sparapani, R. Gale, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation.

M. Horowitz, P. Armand, R. Soiffer, 2014, Blood.

Impact of Conditioning Intensity of Allogeneic Transplantation for Acute Myeloid Leukemia With Genomic Evidence of Residual Disease.

H. Deeg, D. Porter, G. Gui, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Toxicity and efficacy of defined doses of CD4(+) donor lymphocytes for treatment of relapse after allogeneic bone marrow transplant.

D. Neuberg, J. Ritz, R. Soiffer, 1998, Blood.

Cystoscopic Removal of Large Ureteral Calculi1

E. Alyea, 1938 .

Renal response to exercise: urinary findings.

E. Alyea, H. H. Parish, 1958, Journal of the American Medical Association.

Infliximab use in patients with severe graft-versus-host disease and other emerging risk factors of non-Candida invasive fungal infections in allogeneic hematopoietic stem cell transplant recipients: a cohort study.

R. Soiffer, Stephanie J. Lee, F. Marty, 2003, Blood.

Effect of age on the pharmacokinetics of busulfan in patients undergoing hematopoietic cell transplantation; an alliance study (CALGB 10503, 19808, and 100103)

K. Owzar, M. Ratain, R. Vij, 2014, Cancer Chemotherapy and Pharmacology.

The utility of routine chest radiography in the initial evaluation of adult patients with febrile neutropenia patients undergoing HSCT.

R. Soiffer, I. Dagogo-Jack, J. Antin, 2015, Journal of the National Comprehensive Cancer Network : JNCCN.

Prognostic factors for early severe pulmonary complications after hematopoietic stem cell transplantation.

R. Soiffer, E. Weller, J. Antin, 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Clearance of CMV viremia and survival after double umbilical cord blood transplantation in adults depends on reconstitution of thymopoiesis.

J. Ritz, K. Stevenson, P. Armand, 2010, Blood.

Costs of allogeneic hematopoietic cell transplantation with high-dose regimens.

D. Zahrieh, R. Soiffer, Stephanie J. Lee, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Isolation of non‐typhoidal Salmonella from a haematopoietic progenitor cell product

A. Onderdonk, E. Alyea, G. Kao, 2010, Transfusion medicine.

A large single-center experience with allogeneic stem-cell transplantation for peripheral T-cell non-Hodgkin lymphoma and advanced mycosis fungoides/Sezary syndrome.

E. D. Jacobsen, P. Armand, D. Fisher, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Sulfathiazole Therapy in Urinary Tract Infections1

E. Alyea, 1942 .

Emergence of a Clinical Daptomycin-Resistant Staphylococcus aureus Isolate during Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia and Osteomyelitis

S. Pillai, F. Marty, L. Baden, 2006, Journal of Clinical Microbiology.

Phase II Trial of Reduced-Intensity Busulfan/Clofarabine Conditioning with Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Acute Myeloid Leukemia, Myelodysplastic Syndromes, and Acute Lymphoid Leukemia.

K. Ballen, R. Soiffer, Yi-Bin Chen, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Busulfan dose intensity and outcomes in reduced-intensity allogeneic peripheral blood stem cell transplantation for myelodysplastic syndrome or acute myeloid leukemia.

P. Armand, K. Ballen, R. Soiffer, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Validation and Refinement Of The Disease Risk Index For Stratification Of Patients Undergoing Allogeneic Stem Cell Transplantation: A Study Of 13,131 Patients From The Center For International Blood & Marrow Transplant Research

M. Horowitz, R. Soiffer, M. Kalaycio, 2013 .

Interleukin-2 and regulatory T cells in graft-versus-host disease.

J. Ritz, Sashank Prasad, D. Bienfang, 2011, The New England journal of medicine.

Effect of up-front daclizumab when combined with steroids for the treatment of acute graft-versus-host disease: results of a randomized trial.

D. Zahrieh, R. Soiffer, Stephanie J. Lee, 2004, Blood.

Extended Follow-up of Patients Treated with Imatinib Mesylate (Gleevec) for Chronic Myelogenous Leukemia Relapse after Allogeneic Transplantation

J. Ritz, D. DeAngelo, I. Galinsky, 2004, Clinical Cancer Research.

Bortezomib-based graft-versus-host disease prophylaxis in HLA-mismatched unrelated donor transplantation.

J. Ritz, K. Stevenson, P. Armand, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Autologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple myeloma (BMT CTN 0102): a phase 3 biological assignment trial.

N. Geller, A. Krishnan, P. Hari, 2011, The Lancet. Oncology.

The Evolving Role of Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia

M. Davids, E. Alyea, 2015, Current Hematologic Malignancy Reports.

Graft-versus-Leukemia Antigen CML66 Elicits Coordinated B-Cell and T-Cell Immunity after Donor Lymphocyte Infusion

Catherine J. Wu, V. Brusic, E. Reinherz, 2010, Clinical Cancer Research.

Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission.

Catherine J. Wu, J. Ritz, D. Miklos, 2004, Blood.

A novel rapid single nucleotide polymorphism (SNP)-based method for assessment of hematopoietic chimerism after allogeneic stem cell transplantation.

D. Neuberg, J. Ritz, D. Miklos, 2003, Blood.

CHEMOTHERAPY IN NONSPECIFIC INFECTIONS OF THE URINARY TRACT: PRESENT STATUS

L. C. Roberts, E. Alyea, 1940 .

Recent advances in prostatic surgery

E. Alyea, 1937 .

High NPM1-mutant allele burden at diagnosis predicts unfavorable outcomes in de novo AML.

T. Graubert, D. DeAngelo, R. Soiffer, 2018, Blood.

Impact of conditioning regimen intensity on outcome of allogeneic hematopoietic cell transplantation for advanced acute myelogenous leukemia and myelodysplastic syndrome.

J. Ritz, D. DeAngelo, R. Soiffer, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Proteasome inhibition and allogeneic hematopoietic stem cell transplantation: a review.

W. Murphy, L. Welniak, E. Alyea, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Vaso-Ligation a Preventive of Epididymitis Before and After Prostatectomy

E. Alyea, 1928 .

Recurrent genetic HLA loss in AML relapsed after matched unrelated allogeneic hematopoietic cell transplantation.

B. Ebert, M. Ducar, A. Thorner, 2019, Blood advances.

A disease risk index for patients undergoing allogeneic stem cell transplantation.

H. Deeg, J. Ritz, M. Sorror, 2012, Blood.

High‐resolution HLA matching in double‐umbilical‐cord‐blood reduced‐intensity transplantation in adults

B. Yeap, S. Saidman, K. Ballen, 2009, Transfusion.

Functional analysis of clinical response to low-dose IL-2 in patients with refractory chronic graft-versus-host disease.

J. Ritz, S. Nikiforow, J. Whangbo, 2019, Blood advances.

PD-1 modulates regulatory T-cell homeostasis during low-dose interleukin-2 therapy.

J. Ritz, M. Tanimoto, P. Armand, 2017, Blood.

A phase I study of CD25/regulatory T-cell-depleted donor lymphocyte infusion for relapse after allogeneic stem cell transplantation

J. Ritz, S. Nikiforow, P. Armand, 2016, Haematologica.

Rituximab prophylaxis prevents corticosteroid-requiring chronic GVHD after allogeneic peripheral blood stem cell transplantation: results of a phase 2 trial.

J. Ritz, P. Armand, R. Soiffer, 2013, Blood.

Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemia.

C. Perreault, R. Gonin, G. Pichert, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Donor Lymphocyte Infusions Clinical Applications and the Graft‐versus‐Leukemia Effect

E. Alyea, 2008 .

GM-CSF secreting leukemia cell vaccination for MDS/AML after allogeneic HSCT: a randomized, double-blinded, phase 2 trial

Catherine J. Wu, F. Hodi, G. Dranoff, 2021, Blood advances.

Treatment of Sulfanilamide-Resistant Gonorrhea with Sodium Sulf Anilyl-Sulf Anilamide

E. Alyea, W. E. Daniel, 1939 .

Sulfanilamide and Disulfanilamide Concentrations in the Blood and Urine1

E. Alyea, W. E. Daniel, A. Yates, 1939 .

Efficacy, durability, and response predictors of low-dose interleukin-2 therapy for chronic graft-versus-host disease.

J. Ritz, S. Nikiforow, J. Whangbo, 2016, Blood.

Low-Dose Interleukin-2 Therapy Restores Regulatory T Cell Homeostasis in Patients with Chronic Graft-Versus-Host Disease

J. Ritz, P. Armand, R. Soiffer, 2013, Science Translational Medicine.

Infused total nucleated cell dose is a better predictor of transplant outcomes than CD34+ cell number in reduced-intensity mobilized peripheral blood allogeneic hematopoietic cell transplantation

J. Ritz, S. Nikiforow, C. J. Luckey, 2016, Haematologica.

Somatic mutations predict poor outcome in patients with myelodysplastic syndrome after hematopoietic stem-cell transplantation.

D. Neuberg, B. Ebert, P. Stojanov, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

NCI First International Workshop on The Biology, Prevention and Treatment of Relapse after Allogeneic Hematopoietic Cell Transplantation: report from the committee on prevention of relapse following allogeneic cell transplantation for hematologic malignancies.

S. Riddell, D. DeAngelo, M. Bishop, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Autologous and allogeneic stem cell transplantations for poor-risk chronic lymphocytic leukemia.

J. Gribben, D. Neuberg, L. Sequist, 2005, Blood.

Long-term follow-up of autologous bone marrow transplantation in patients with relapsed follicular lymphoma.

J. Gribben, D. Neuberg, J. Ritz, 1999, Blood.

Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of age.

J. Gribben, J. Ritz, D. DeAngelo, 2004, Blood.

Sirolimus and tacrolimus without methotrexate as graft-versus-host disease prophylaxis after matched related donor peripheral blood stem cell transplantation.

D. Miklos, D. Fisher, R. Soiffer, 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Sirolimus, tacrolimus, and low-dose methotrexate for graft-versus-host disease prophylaxis in mismatched related donor or unrelated donor transplantation.

Catherine J. Wu, D. Miklos, R. Soiffer, 2003, Blood.

Comparable outcome with T-cell-depleted unrelated-donor versus related-donor allogeneic bone marrow transplantation.

J. Gribben, J. Friedberg, A. Freedman, 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Outcomes in patients age 70 or older undergoing allogeneic hematopoietic stem cell transplantation for hematologic malignancies.

P. Armand, K. Ballen, R. Soiffer, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Interleukin-1 blockade does not prevent acute graft-versus-host disease: results of a randomized, double-blind, placebo-controlled trial of interleukin-1 receptor antagonist in allogeneic bone marrow transplantation.

D. Neuberg, R. Soiffer, Stephanie J. Lee, 2002, Blood.

CD6-depleted allogeneic bone marrow transplantation for acute leukemia in first complete remission.

D. Fairclough, J. Ritz, D. Fisher, 1997, Blood.

Lack of impact of umbilical cord blood unit processing techniques on clinical outcomes in adult double cord blood transplant recipients.

J. Ritz, S. Nikiforow, E. Shpall, 2017, Cytotherapy.

Immune reconstitution after double umbilical cord blood stem cell transplantation: comparison with unrelated peripheral blood stem cell transplantation.

J. Ritz, K. Stevenson, P. Armand, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Donor-derived second hematologic malignancies after cord blood transplantation.

B. Yeap, K. Ballen, R. Soiffer, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Low-dose IL-2 selectively activates subsets of CD4+ Tregs and NK cells.

Hongye Liu, Masahiro Hirakawa, Kazuyuki Murase, 2016, JCI insight.

transplantation disease prophylaxis in mismatched related donor or unrelated donor Sirolimus, tacrolimus, and low-dose methotrexate for graft-versus-host

Catherine J. Wu, D. Miklos, R. Soiffer, 2013 .

Daratumumab for Delayed Red-Cell Engraftment after Allogeneic Transplantation.

J. Connors, R. Kaufman, E. Alyea, 2018, The New England journal of medicine.

CD6+ donor marrow T-cell depletion as the sole form of graft-versus-host disease prophylaxis in patients undergoing allogeneic bone marrow transplant from unrelated donors.

J. Ritz, A. Freedman, P. Mauch, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Reduced-intensity conditioning stem cell transplantation: comparison of double umbilical cord blood and unrelated donor grafts.

J. Ritz, P. Armand, K. Ballen, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A phase II study of reduced intensity double umbilical cord blood transplantation using fludarabine, melphalan, and low dose total body irradiation

J. Ritz, S. Nikiforow, P. Armand, 2019, Bone Marrow Transplantation.

Syngeneic donor hematopoietic stem cell transplantation is associated with high rates of engraftment syndrome.

Catherine J. Wu, P. Armand, R. Soiffer, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impact of Thrombotic Microangiopathy on Renal Outcomes and Survival after Hematopoietic Stem Cell Transplantation.

D. Leaf, J. Ritz, P. Armand, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

in First Complete Remission CD6-Depleted Allogeneic Bone Marrow Transplantation for Acute Leukemia

D. Fairclough, D. Fisher, R. Soiffer, 2013 .

CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.

D. Fairclough, J. Ritz, A. Freedman, 1997, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Donor-speciﬁc anti-HLA antibodies predict outcome in double umbilical cord blood transplantation

J. Ritz, P. Armand, K. Ballen, 2011 .

A phase 1 study of donor regulatory T-cell infusion plus low-dose interleukin-2 for steroid-refractory chronic graft-vs-host disease

J. Ritz, S. Nikiforow, J. Whangbo, 2022, Blood advances.

Venous thromboembolism is associated with graft-versus-host disease and increased non-relapse mortality after allogeneic hematopoietic stem cell transplantation

S. Nikiforow, P. Armand, R. Soiffer, 2017, Haematologica.

phase 2 trial after allogeneic peripheral blood stem cell transplantation: results of a Rituximab prophylaxis prevents corticosteroid-requiring chronic GVHD

J. Ritz, P. Armand, R. Soiffer, 2014 .

Post-transplantation B cell activating factor and B cell recovery before onset of chronic graft-versus-host disease.

J. Ritz, P. Armand, C. Jacobson, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Effective posttransplant antitumor immunity is associated with TLR-stimulating nucleic acid-immunoglobulin complexes in humans.

N. Hacohen, D. Neuberg, Catherine J. Wu, 2011, The Journal of clinical investigation.

Readmissions after Umbilical Cord Blood Transplantation and Impact on Overall Survival.

R. Soiffer, L. Spring, Shuli Li, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation.

J. Ritz, P. Westervelt, J. Dipersio, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Low telomerase activity in CD4+ regulatory T cells in patients with severe chronic GVHD after hematopoietic stem cell transplantation.

J. Ritz, R. Soiffer, Gregory Bascug, 2011, Blood.

Excellent Disease-Free Survival after Double Cord Blood Transplantation Using a Reduced Intensity Chemotherapy Only Conditioning Regimen in a Diverse Adult Population.

B. Yeap, K. Ballen, R. Soiffer, 2005 .

White blood cell recovery after allogeneic hematopoietic cell transplantation predicts clinical outcome

J. Ritz, P. Armand, R. Soiffer, 2014, American journal of hematology.

Absolute lymphocyte count recovery after allogeneic hematopoietic stem cell transplantation predicts clinical outcome.

J. Ritz, P. Armand, R. Soiffer, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Outcome and prognostic factors for patients who relapse after allogeneic hematopoietic stem cell transplantation.

P. Armand, R. Soiffer, C. Cutler, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A prognostic score for patients with acute leukemia or myelodysplastic syndromes undergoing allogeneic stem cell transplantation.

J. Ritz, P. Armand, R. Soiffer, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Reconstitution of T-cell receptor repertoire diversity following T-cell depleted allogeneic bone marrow transplantation is related to hematopoietic chimerism.

D. Neuberg, J. Ritz, R. Soiffer, 2000, Blood.

High Levels of Donor Chimerism Early after Non-Myeloablative Transplantation Predictive of Overall and Progression Free Survival but Not Risk of Acute Graft Versus Host Disease for Patients with AML or MDS.

J. Gribben, J. Ritz, D. DeAngelo, 2004 .

Donor chimerism early after reduced-intensity conditioning hematopoietic stem cell transplantation predicts relapse and survival.

J. Ritz, S. Nikiforow, P. Armand, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Absolute Lymphocyte Count Recovery after Allogeneic Hematopoietic Stem Cell Transplantation Predicts Clinical Outcome

J. Ritz, P. Armand, R. Soiffer, 2014 .

Risk factors for cytomegalovirus reactivation after CD6+ T-cell–depleted allogeneic bone marrow transplantation1

D. Zahrieh, R. Soiffer, E. Weller, 2002, Transplantation.

Impact of diagnostic genetics on remission MRD and transplantation outcomes in older AML patients.

Shannon R. McCurdy, J. Ritz, M. Carroll, 2022, Blood.

Guillain-Barré syndrome following allogeneic bone marrow transplantation

P. Wen, R. Herbst, R. Soiffer, 1997, Neurology.

A Bortezomib-Based Regimen Offers Promising Survival and Graft-versus-Host Disease Prophylaxis in Myeloablative HLA-Mismatched and Unrelated Donor Transplantation: A Phase II Trial.

J. Ritz, S. Nikiforow, P. Armand, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

receptor associated with antibody response to BCMA, a plasma-cell membrane Graft-versus-tumor response in patients with multiple myeloma is

Bingyan Wu, Catherine J. Wu, N. Munshi, 2013 .

Graft-versus-tumor response in patients with multiple myeloma is associated with antibody response to BCMA, a plasma-cell membrane receptor.

Bingyan Wu, Catherine J. Wu, N. Munshi, 2005, Blood.

Outcomes of human leukocyte antigen-matched sibling donor hematopoietic cell transplantation in chronic lymphocytic leukemia: myeloablative versus reduced-intensity conditioning regimens.

J. Cortes, M. Aljurf, I. Lewis, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Long-Term Follow-up of Reduced Intensity Allogeneic Stem Cell Transplantation for Chronic Lymphocytic Leukemia: Prognostic Model to Predict Outcome

J. Gribben, Catherine J. Wu, J. Ritz, 2012, Leukemia.

A Comparison of the Myeloablative Conditioning Regimen Fludarabine/Busulfan with Cyclophosphamide/Total Body Irradiation, for Allogeneic Stem Cell Transplantation in the Modern Era: A Cohort Analysis.

J. Ritz, S. Nikiforow, P. Armand, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

TRANSPLANTATION Ef ﬁ cacy, durability, and response predictors of low-dose interleukin-2 therapy for chronic graft-versus-host disease

J. Ritz, S. Nikiforow, J. Whangbo, 2016 .

Comparison of T-cell-depleted and non-T-cell-depleted unrelated donor transplantation for hematologic diseases: clinical outcomes, quality of life, and costs.

D. Zahrieh, R. Soiffer, Stephanie J. Lee, 2002, Blood.

Complete response to donor lymphocyte infusion in multiple myeloma is associated with antibody responses to highly expressed antigens.

Catherine J. Wu, N. Munshi, G. Dranoff, 2004, Blood.

Immunologic effects of prophylactic donor lymphocyte infusion after allogeneic marrow transplantation for multiple myeloma.

Catherine J. Wu, J. Ritz, R. Soiffer, 2002, Blood.

Characterization of T cell repertoire in patients with graft-versus-leukemia after donor lymphocyte infusion.

D. Neuberg, J. Ritz, R. Soiffer, 1997, The Journal of clinical investigation.

Allogeneic Hematopoietic Cell Transplantation for Adult Chronic Myelomonocytic Leukemia.

J. Cortes, M. Aljurf, M. Tallman, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Clinical Practice Recommendations for Use of Allogeneic Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation.

J. Gribben, E. Montserrat, F. Awan, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic hematopoietic cell transplantation after prior targeted therapy for high-risk chronic lymphocytic leukemia.

Catherine J. Wu, J. Ritz, S. Nikiforow, 2020, Blood advances.

Incidence, predictors, and outcomes of veno-occlusive disease/sinusoidal obstruction syndrome after reduced intensity allogeneic hematopoietic cell transplantation.

P. Richardson, S. Nikiforow, P. Armand, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Engraftment of autologous and allogeneic marrow HPCs after myeloablative therapy

J. Gribben, D. Neuberg, J. Ritz, 2004, Transfusion.

associated with antibody responses to highly expressed antigens Complete response to donor lymphocyte infusion in multiple myeloma is

Catherine J. Wu, N. Munshi, S. Chiaretti, 2013 .

Comparison of Tacrolimus and Sirolimus (Tac/Sir) versus Tacrolimus, Sirolimus, and mini-methotrexate (Tac/Sir/MTX) as acute graft-versus-host disease prophylaxis after reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation.

P. Armand, R. Soiffer, C. Cutler, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Improved survival in lymphoma patients receiving sirolimus for graft-versus-host disease prophylaxis after allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning.

A. LaCasce, A. Freedman, P. Armand, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Sirolimus, tacrolimus, and low-dose methotrexate as graft-versus-host disease prophylaxis in related and unrelated donor reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation.

R. Soiffer, Shuli Li, C. Cutler, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic transplantation with reduced-intensity conditioning for Hodgkin and non-Hodgkin lymphoma: importance of histology for outcome.

A. LaCasce, A. Freedman, P. Armand, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A Phase I Trial of SYK Inhibition with Fostamatinib in the Prevention and Treatment of Chronic Graft-Versus-Host Disease: SYK Inhibition in Chronic GVHD.

Kristina M. Wiggins, M. Grunwald, D. Rizzieri, 2022, Transplantation and cellular therapy.

Graft-Versus-Leukemia Antigen CML66 Elicits Coordinated B And T Cell Immunity After Donor Lymphocyte Infusion

Catherine J. Wu, J. Ritz, R. Soiffer, 2010 .

CML28 is a broadly immunogenic antigen, which is overexpressed in tumor cells.

P. Kantoff, Catherine J. Wu, G. Dranoff, 2002, Cancer research.

Reconstitution of T-cell receptor repertoire diversity following T-cell depleted allogeneic bone marrow transplantation is related to hematopoietic chimerism

D. Neuberg, Catherine J. Wu, J. Ritz, 2000 .

PERSISTENCE OF MYELOID PROGENITOR CELLS EXPRESSING BCR-ABL MRNA AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA

J. Ritz, R. Soiffer, G. Pichert, 1994 .

Bone marrow studies in carcinoma of the prostate.

R. Rundles, E. Alyea, 1949, The Journal of urology.

Vaccination with autologous myeloblasts admixed with GM-K562 cells in patients with advanced MDS or AML after allogeneic HSCT.

M. Mihm, G. Dranoff, J. Ritz, 2017, Blood advances.

Persistence of myeloid progenitor cells expressing BCR-ABL mRNA after allogeneic bone marrow transplantation for chronic myelogenous leukemia.

J. Ritz, R. Soiffer, G. Pichert, 1994, Blood.

Sirolimus is associated with veno-occlusive disease of the liver after myeloablative allogeneic stem cell transplantation.

P. Richardson, K. Stevenson, P. Armand, 2008, Blood.

Antigen targets of remission-inducing immune therapy are expressed on CML progenitor cells

Vladimir Brusic, Donna Neuberg, Wandi Zhang, 2010 .

Reversal of in situ T-cell exhaustion during effective human antileukemia responses to donor lymphocyte infusion.

N. Hacohen, Catherine J. Wu, F. Hodi, 2014, Blood.

antileukemia responses to donor lymphocyte infusion Reversal of in situ T-cell exhaustion during effective human

N. Hacohen, Catherine J. Wu, F. Hodi, 2014 .

Introduction to the reports from the National Cancer Institute First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.

N. Kröger, D. Porter, C. June, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Modulating graft-versus-host disease to enhance the graft-versus-leukemia effect.

E. Alyea, 2008, Baillière's Best Practice & Research: Clinical Haematology.

Adoptive immunotherapy:insights from donor lymphocyte infusions

E. Alyea, 2000, Transfusion.

Comparison of outcomes of allogeneic transplantation for chronic myeloid leukemia with cyclophosphamide in combination with intravenous busulfan, oral busulfan, or total body irradiation.

J. Cortes, M. Aljurf, J. Szer, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Prognostic Score and Cytogenetic Risk Classification for Chronic Lymphocytic Leukemia Patients: Center for International Blood and Marrow Transplant Research Report

J. Mehta, M. Perales, N. Saba, 2019, Clinical Cancer Research.

Comparative Outcome of Myeloablative and Reduced Intensity Allogeneic Stem Cell Transplantation for Chronic Lymphocytic Leukemia.

J. Gribben, J. Ritz, K. Stevenson, 2008 .

Does total body irradiation conditioning improve outcomes of myeloablative human leukocyte antigen-identical sibling transplantations for chronic lymphocytic leukemia?

J. Cortes, M. Aljurf, I. Lewis, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Bortezomib-based immunosuppression after reduced-intensity conditioning hematopoietic stem cell transplantation: randomized phase II results

J. Ritz, S. Nikiforow, P. Armand, 2018, Haematologica.

HLA mismatch and clinical outcome after unrelated donor (URD) non-myeloablative hematopoietic stem cell transplantation (NST)

R. Soiffer, E. Milford, C. Cutler, 2005 .

Next‐generation sequencing‐based detection of circulating tumour DNA After allogeneic stem cell transplantation for lymphoma

V. Carlton, J. Ritz, M. Faham, 2016, British journal of haematology.

transplantation Prostaglandin-modulated umbilical cord blood hematopoietic stem cell

L. Zon, W. Goessling, C. Desponts, 2014 .

Sirolimus and thrombotic microangiopathy after allogeneic stem cell transplantation

Sigui Li, R. Soiffer, C. Magee, 2005 .

The addition of sirolimus to the graft‐versus‐host disease prophylaxis regimen in reduced intensity allogeneic stem cell transplantation for lymphoma: a multicentre randomized trial

P. Armand, R. Soiffer, Yi-Bin Chen, 2016, British journal of haematology.

Reduced-intensity conditioning hematopoietic stem cell transplantation in patients over 60 years: hematologic malignancy outcomes are not impaired in advanced age.

J. Ritz, P. Armand, R. Soiffer, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Efficacy of immune suppression tapering in treating relapse after reduced intensity allogeneic stem cell transplantation

S. Nikiforow, P. Armand, R. Soiffer, 2015, Haematologica.

Rituxan for steroid-refractory chronic GVHD

J. Ritz, D. Miklos, D. Bienfang, 2005 .

Rituximab Therapy for Steroid-Refractory Chronic GVHD: Safety and Efficacy Analysis.

J. Ritz, D. Miklos, D. Bienfang, 2004 .

Impact of cytogenetics on outcome of de novo and therapy-related AML and MDS after allogeneic transplantation.

J. Ritz, P. Armand, D. DeAngelo, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Dose-escalated interleukin-2 therapy for refractory chronic graft-versus-host disease in adults and children.

J. Ritz, S. Nikiforow, J. Whangbo, 2019, Blood advances.

Increased mitochondrial apoptotic priming of human regulatory T cells after allogeneic hematopoietic stem cell transplantation

A. Letai, J. Ritz, P. Armand, 2014, Haematologica.

Use of matched unrelated donors compared with matched related donors is associated with lower relapse and superior progression-free survival after reduced-intensity conditioning hematopoietic stem cell transplantation.

J. Ritz, P. Armand, R. Soiffer, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic hematopoietic cell transplantation outcomes in patients with Richter’s transformation

Catherine J. Wu, J. Ritz, S. Nikiforow, 2021, Haematologica.

Denileukin diftitox (ONTAK) as targeted therapy against steroid refractory graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT)

J. Ritz, D. Zahrieh, R. Soiffer, 2004 .

Outcome and Prognostic Factors for Patients Who Relapse After Allogeneic Stem Cell Transplantation.

P. Armand, R. Soiffer, C. Cutler, 2012 .

Feasibility, Safety, Efficacy And Immunologic Impact Of Daily Ultra-Low-Dose Interleukin-2 For Steroid-Refractory Chronic Graft-Versus-Host Disease: A Phase I Study

J. Ritz, K. Stevenson, P. Armand, 2010 .

High Rate of Second Malignancies after Reduced Intensity Double Cord Blood Transplants in Adults.

B. Yeap, K. Ballen, R. Soiffer, 2008 .

myelogenous leukemia after allogeneic bone marrow transplantation for chronic Persistence of myeloid progenitor cells expressing BCR-ABL mRNA

J. Ritz, R. Soiffer, G. Pichert, 2011 .

TRANSPLANTATION Validation and re fi nement of the Disease Risk Index for allogeneic stem cell transplantation

M. Horowitz, P. Armand, R. Soiffer, 2014 .

transplantation and primary biliary cirrhosis hematologic malignancies after allogeneic hematopoietic stem cell Differential epitope mapping of antibodies to PDC-E2 in patients with

N. Munshi, J. Ritz, Sigui Li, 2013 .

Immunomodulatory effects of donor lymphocyte infusions following allogeneic bone marrow transplantation

J. Ritz, R. Soiffer, E. Alyea, 1995, Journal of clinical apheresis.

transplantation in adults depends on reconstitution of thymopoiesis Clearance of CMV viremia and survival after double umbilical cord blood

J. Ritz, K. Stevenson, P. Armand, 2013 .

Early Clinical Predictors of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Myeloablative Stem Cell Transplantation.

P. Richardson, S. Nikiforow, P. Armand, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

and costs transplantation for hematologic diseases: clinical outcome, quality of life, Comparison of T-cell depleted and non-T-cell depleted unrelated donor

D. Zahrieh, Stephanie J. Lee, E. Weller, 2013 .

Does iron overload really matter in stem cell transplantation?

R. Kwong, E. Neufeld, P. Armand, 2011, American journal of hematology.

Impact of Genetic Mutations on the Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Acute Myeloid Leukemia with Antecedent Myeloproliferative Neoplasm

U. Popat, J. Capo-Chichi, K. Ahn, 2020 .

Graft-versus-host disease of the CNS after allogeneic bone marrow transplantation.

P. Wen, S. Kesari, U. Degirolami, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Falling chimerism after reduced intensity conditioning transplantation.

E. Alyea, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Assessment of Impact of HLA Type on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia.

M. Aljurf, J. Szer, M. Tallman, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A Phase II Study of Allogeneic Transplantation for Older Patients with AML in First Complete Remission Using a Reduced Intensity Conditioning Regimen: Results From CALGB 100103/BMT CTN 0502

K. Owzar, R. Vij, R. Larson, 2012 .

Tyrosine Kinase Inhibitors with or without Donor Lymphocyte Infusion Continue to Provide Long-Term Survival after Relapse of Chronic Myeloid Leukemia Following Hematopoietic Cell Transplantation

U. Popat, R. Sobecks, W. Saber, 2018, Blood.

High-dose therapy with single autologous transplantation versus chemotherapy for newly diagnosed multiple myeloma: A systematic review and meta-analysis of randomized controlled trials.

N. Munshi, P. Richardson, B. Djulbegovic, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Maintenance Tyrosine Kinase Inhibitors Following Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia: A Center for International Blood and Marrow Transplant Research Study

M. Aljurf, J. Szer, R. Gale, 2020 .

igh-dose Therapy with Single Autologous ransplantation versus Chemotherapy for Newly iagnosed Multiple Myeloma : A Systematic Review nd Meta-analysis of Randomized Controlled Trials

N. Munshi, P. Richardson, B. Djulbegovic, 2007 .

Risk factors for readmission after allogeneic hematopoietic stem cell transplantation and impact on overall survival.

R. Soiffer, L. Spring, Shuli Li, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Hyperlipidemia and statin use after allogeneic hematopoietic stem cell transplantation.

P. Armand, R. Soiffer, J. Plutzky, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Sirolimus, Tacrolimus and Reduced-Dose Methotrexate as Graft Versus Host Disease (GVHD)Prophylaxis after Non-Myeloablative Stem Cell Transplantation: Low Incidence of Acute GVHD Compared with Tacrolimus/Methotrexate or Cyclosporine/Prednisone.

J. Gribben, J. Ritz, D. Fisher, 2004 .

Prognostic Score and Cytogenetic Risk Classification for Chronic Lymphocyteic Leukemia Patients Who Underwent Reduced Intensity Conditioning Allogeneit HCT: A CIBMTR Report

M. Davids, U. Popat, K. Ahn, 2017 .

Reperfusion-induced arrhythmias are not prevented by ibuprofen in isolated rat heart.

M. Bernier, D. Hearse, E. Alyea, 1990, Free radical biology & medicine.

allogeneic hematopoietic stem cell transplant recipients: a cohort study invasive fungal infections in -Candida other emerging risk factors of non Infliximab use in patients with severe graft-versus-host disease and

R. Soiffer, Stephanie J. Lee, F. Marty, 2011 .

Outcomes after Allogeneic Stem Cell Transplantation in Patients with Double-Hit and Double-Expressor Lymphoma.

W. Chan, D. Weisenburger, A. Nademanee, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impact of physician assistants on the outcomes of patients with acute myelogenous leukemia receiving chemotherapy in an academic medical center.

D. DeAngelo, R. Soiffer, R. Stone, 2013, Journal of oncology practice.

mpact of Conditioning Regimen Intensity n Outcome of Allogeneic Hematopoietic Cell ransplantation for Advanced Acute Myelogenous eukemia and Myelodysplastic Syndrome

J. Ritz, D. DeAngelo, R. Soiffer, 2006 .

337: Double umbilical cord blood transplantation with reduced intensity conditioning and sirolimus-based GVHD prophylaxis

K. Ballen, R. Soiffer, T. Spitzer, 2007 .

Maintenance tyrosine kinase inhibitors following allo-HCT for chronic myeloid leukemia: A CIBMTR Study.

M. Aljurf, J. Szer, R. Gale, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Posttransplant Immunotherapy with a GM-CSF-Based Tumor Vaccine (GVAX®) Following Autologous Stem Cell Transplant (ASCT) for Acute Myeloid Leukemia (AML).

W. Stock, D. DeAngelo, L. Damon, 2004 .

The impact of geographic proximity to transplant center on outcomes after allogeneic hematopoietic stem cell transplantation.

P. Armand, R. Soiffer, J. Blossom, 2012, Biology of Blood and Marrow Transplantation.

undergoing myeloablative stem cell transplantation Prognostic impact of elevated pre-transplant serum ferritin in patients

P. Armand, C. Cutler, Haesook T. Kim, 2013 .

Genetic Alterations at Diagnosis Predict Outcome of AML Patients Age 60 or Older Undergoing Allogeneic Transplantation in First Remission.

Shannon R. McCurdy, M. Carroll, M. Perales, 2019, Blood.

31: Comprehensive Typing of 1143 Single Nucleotide Polymorphisms (SNP) in 220 Immunoregulatory Genes Demonstrates That Polymorphisms in CCL3, CCL4 and CCL27 Modulate the Risk of Acute Graft Versus Host Disease (GVHD)

J. Ritz, Cheng Li, R. Soiffer, 2008 .

Graft-Versus-Leukemia Antigen CML66 Elicits Coordinated B and T Cell Immunity After Donor Lymphocyte Infusion.

Catherine J. Wu, E. Reinherz, J. Ritz, 2009 .

Priapism of Unusual Etiology1. Case Report

E. Alyea, W. A. Frontz, 1928 .

Readmissions following umbilical cord blood stem cell transplantation.

R. Soiffer, L. Spring, Shuli Li, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

CD25+ Regulatory T CELL-Depleted Donor Lymphocyte Infusion for Relapse After Allogeneic Transplantation – A PHASE 1 Study

J. Ritz, S. Nikiforow, P. Armand, 2013 .

Ureterocutaneous anastomosis. II. A new urine collection apparatus to prevent stricture.

J. Glenn, E. Alyea, 1960, Transactions. American Urological Association. Southeastern Section.

Ureterocutaneous anastomosis. II. A new urine collection apparatus to prevent stricture.

J. Glenn, E. Alyea, 1960, Journal of Urology.

FT1050 (16,16-dimethyl Prostaglandin E2)-Enhanced Umbilical Cord Blood Accelerates Hematopoietic Engraftment After Reduced Intensity Conditioning and Double Umbilical Cord Blood Transplantation

W. Goessling, C. Desponts, J. Ritz, 2011 .

Time to reconsider the role of allogeneic transplantation for patients with acute myeloid leukemia and NPM1 mutation?

E. Alyea, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impaired Immune Reconstitution after Cord Blood Transplantation in Adults Is Associated with Delayed Recovery but Not Functional Impairment of CD8+T Cells.

J. Ritz, K. Stevenson, K. Ballen, 2007 .

Routine screening for psychosocial distress following hematopoietic stem cell transplantation

P. Richardson, D. Fisher, R. Soiffer, 2005, Bone Marrow Transplantation.

A Prospective Randomized Double Blind Phase 3 Clinical Trial of Anti- T Lymphocyte Globulin (ATLG) to Assess Impact on Chronic Graft-Versus-Host Disease (cGVHD) Free Survival in Patients Undergoing HLA Matched Unrelated Myeloablative Hematopoietic Cell Transplantation (HCT)

J. Ritz, P. Westervelt, J. Dipersio, 2016 .

Outcome in patients with myelodysplastic syndrome after autologous bone marrow transplantation for non-Hodgkin's lymphoma.

J. Gribben, A. LaCasce, J. Friedberg, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

CD8+ cell depletion of donor lymphocyte infusions using cd8 monoclonal antibody-coated high-density microparticles (CD8-HDM) after allogeneic hematopoietic stem cell transplantation: a pilot study

D. Neuberg, R. Soiffer, R. Champlin, 2004, Bone Marrow Transplantation.

Reply to J. Mehta

A. LaCasce, A. Freedman, P. Armand, 2009 .

A phase I/II double-blind, placebo-controlled study of recombinant human interleukin-11 for mucositis and acute GVHD prevention in allogeneic stem cell transplantation

D. Neuberg, R. Soiffer, S. Sonis, 2002, Bone Marrow Transplantation.

KIR ligand incompatibility is not associated with relapse reduction after double umbilical cord blood transplantation

J. Ritz, P. Armand, R. Soiffer, 2013, Bone Marrow Transplantation.

Proteomics To Identify Novel Immune-Targeted CML Stem Cell Antigens.

Catherine J. Wu, J. Ritz, D. Zahrieh, 2007 .

54: Inclusion of Sirolimus in the GVHD Prophylaxis Regimen is Associated with Improved Survival in Patients with Lymphoma Undergoing Allogeneic Transplantation

A. LaCasce, A. Freedman, P. Armand, 2008 .

Tacrolimus and Sirolimus without Methotrexate as Acute GVHD Prophylaxis after Matched Related Donor Reduced Intensity Conditioning (RIC) Stem Cell Transplantation (SCT).

P. Armand, R. Soiffer, Shuli Li, 2007 .

PD-1 modulates regulatory T cell homeostasis during low-dose IL-2 therapy

J. Ritz, M. Tanimoto, P. Armand, 2017 .

A Phase I/Ib Study of Nivolumab for Relapsed Hematologic Malignancies after Allogeneic Hematopoietic Cell Transplantation (alloHCT)

Catherine J. Wu, S. Nikiforow, P. Armand, 2018, Blood.

Prostaglandin-modulated umbilical cord blood hematopoietic stem cell transplantation.

L. Zon, W. Goessling, C. Desponts, 2013, Blood.

Quantitation of T-cell neogenesis in vivo after allogeneic bone marrow transplantation in adults.

D. Neuberg, J. Ritz, S. Kalams, 2001, Blood.

Quality of life associated with acute and chronic graft-versus-host disease

R. Soiffer, C. Cutler, Haesook T. Kim, 2006, Bone Marrow Transplantation.

Allotransplantation for multiple myeloma.

E. Alyea, K. Anderson, 2001, Cancer journal.

Circulating T follicular helper cells with increased function during chronic graft-versus-host disease.

J. Ritz, S. Nikiforow, P. Armand, 2016, Blood.

Syngeneic donor hematopoietic stem cell transplantation is associated with high rates of engraftment syndrome.

Catherine J. Wu, P. Armand, R. Soiffer, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

α1-Antitrypsin infusion for treatment of steroid-resistant acute graft-versus-host disease.

T. Braun, R. Soiffer, C. Dinarello, 2018, Blood.

Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma.

A. LaCasce, D. Neuberg, B. Ebert, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Detection of a potent humoral response associated with immune-induced remission of chronic myelogenous leukemia.

D. Neuberg, G. Dranoff, J. Ritz, 2000, The Journal of clinical investigation.

Autologous CLL cell vaccination early after transplant induces leukemia-specific T cells.

D. Neuberg, Catherine J. Wu, G. Dranoff, 2013, The Journal of clinical investigation.

Mapping the evolution of T cell states during response and resistance to adoptive cellular therapy.

Shuqiang Li, K. Livak, E. Azizi, 2021, Cell reports.

Comparative outcomes of T-cell-depleted and non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: impact of donor lymphocyte infusion.

J. Ritz, R. Soiffer, E. Weller, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Myeloablative vs reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chronic myeloid leukemia.

U. Popat, M. Kalaycio, Z. DeFilipp, 2018, Blood advances.

Rituximab prophylaxis prevents corticosteroid-requiring chronic GVHD after allogeneic peripheral blood stem cell transplantation: results of a phase 2 trial.

J. Ritz, P. Armand, R. Soiffer, 2013, Blood.

Immune reconstitution after double umbilical cord blood stem cell transplantation: comparison with unrelated peripheral blood stem cell transplantation.

J. Ritz, K. Stevenson, P. Armand, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Bortezomib-based graft-versus-host disease prophylaxis in HLA-mismatched unrelated donor transplantation.

J. Ritz, K. Stevenson, P. Armand, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Changes in T cell receptor repertoire associated with graft-versus-tumor effect and graft-versus-host disease in patients with relapsed multiple myeloma after donor lymphocyte infusion

D. Neuberg, J. Ritz, R. Soiffer, 2000, Bone Marrow Transplantation.

Low-Dose Interleukin-2 Therapy Enhances Cytotoxicity of CD56bright NK Cells in Patients with Chronic Gvhd

J. Ritz, S. Nikiforow, J. Whangbo, 2018, Blood.

Pre-transplantation iron chelation in patients with MDS or acute leukemia and iron overload undergoing myeloablative allo-SCT

R. Kwong, E. Neufeld, P. Armand, 2013, Bone Marrow Transplantation.

N. Geller, A. Krishnan, P. Hari, 2011, The Lancet. Oncology.

Outcome after autologous and allogeneic stem cell transplantation for patients with multiple myeloma: impact of graft-versus-myeloma effect

J. Gribben, P. Richardson, J. Ritz, 2003, Bone Marrow Transplantation.

Double Umbilical Cord Blood Transplantation with Reduced Intensity Conditioning and Sirolimus-Based GVHD Prophylaxis.

P. Armand, K. Ballen, R. Soiffer, 2007 .

Clearance of CMV viremia and survival after double umbilical cord blood transplantation in adults depends on reconstitution of thymopoiesis.

J. Ritz, K. Stevenson, P. Armand, 2010, Blood.